Position in SCLX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$59,632
-$182,488 QoQ
Shares Held
8,954
-54.9% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $4,719,329,783 across 18 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,091,983 | $1,004,373,202 | |
| 2 | AZN |
Astrazeneca PLC
|
3,705,472 | $730,793,186 | |
| 3 | JNJ |
Johnson & Johnson
|
2,832,497 | $692,375,564 | |
| 4 | ABBV |
AbbVie Inc.
|
2,089,885 | $454,529,087 | |
| 5 | PFE |
Pfizer Inc
|
15,493,259 | $435,050,711 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,779,106 | $334,298,659 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,300,271 | $320,588,766 | |
| 8 | AMGN |
Amgen Inc
|
828,097 | $291,365,928 |
All Filings in SCLX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,632 | 8,954 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $242,120 | 19,846 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||